CCR7+ selected gene-modified T cells maintain a central memory phenotype and display enhanced persistence in peripheral blood in vivo

JOURNAL ARTICLE published December 2017 in Journal for ImmunoTherapy of Cancer

Research funded by Bloodwise (13031)

Authors: Gray Kueberuwa | Hannah Gornall | Erik Marcelo Alcantar-Orozco | Deborah Bouvier | Zainul Abedin Kapacee | Robert Edward Hawkins | David Edward Gilham

Prime-boost vaccination targeting prostatic acid phosphatase (PAP) in patients with metastatic castration-resistant prostate cancer (mCRPC) using Sipuleucel-T and a DNA vaccine

JOURNAL ARTICLE published December 2018 in Journal for ImmunoTherapy of Cancer

Research funded by National Cancer Institute (P30 CA014520)

Authors: Ellen Wargowski | Laura E. Johnson | Jens C. Eickhoff | Lauren Delmastro | Mary Jane Staab | Glenn Liu | Douglas G. McNeel

First-in-human phase I study of immunomodulatory E7046, an antagonist of PGE₂-receptor E-type 4 (EP4), in patients with advanced cancers

JOURNAL ARTICLE published June 2020 in Journal for ImmunoTherapy of Cancer

Authors: David S Hong | Aparna Parikh | Geoffrey I Shapiro | Andrea Varga | Aung Naing | Funda Meric-Bernstam | Özlem Ataman | Larisa Reyderman | Terri A Binder | Min Ren | Mingjie Liu | Satish Dayal | Amy Y Siu | Pallavi Sachdev | Lucy Xu | Vijay Bhagawati-Prasad | Ilian Tchakov | Chean Eng Ooi | Xingfeng Bao | Aurelien Marabelle

Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T cell therapy

JOURNAL ARTICLE published May 2021 in Journal for ImmunoTherapy of Cancer

Authors: Abraham Nissani | Shaked Lev-Ari | Tomer Meirson | Elad Jacoby | Nethanel Asher | Guy Ben-Betzalel | Orit Itzhaki | Ronnie Shapira-Frommer | Jacob Schachter | Gal Markel | Michal J. Besser

Intratumoral administration of CD1c (BDCA-1)⁺and CD141 (BDCA-3)⁺myeloid dendritic cells in combination with talimogene laherparepvec in immune checkpoint blockade refractory advanced melanoma patients: a phase I clinical trial

JOURNAL ARTICLE published September 2022 in Journal for ImmunoTherapy of Cancer

Research funded by Kom op tegen Kanker (Stand up to Cancer), the Flemish cancer society (11102) | Stichting Tegen Kanker (2016-128) | Oncology Center Vrije Universiteit Brussel (N/A)

Authors: Julia Katharina Schwarze | Jens Tijtgat | Gil Awada | Louise Cras | Angela Vasaturo | Christopher Bagnall | Ramses Forsyth | Inès Dufait | Sandra Tuyaerts | Ivan Van Riet | Bart Neyns

Exploration of modified progression-free survival as a novel surrogate endpoint for overall survival in immuno-oncology trials

JOURNAL ARTICLE published April 2021 in Journal for ImmunoTherapy of Cancer

Research funded by National Key R&D Program of China (2018YFC1313300)

Authors: Zi-Xian Wang | Hao-Xiang Wu | Li Xie | Wu-Hao Lin | Fei Liang | Jin Li | Zhi-Min Yang | Rui-Hua Xu

597 The role of CCL20 in mediating regulatory T cell infiltration and resistance to radiotherapy in head and neck squamous cell carcinoma

JOURNAL ARTICLE published November 2021 in Journal for ImmunoTherapy of Cancer

Authors: Cleopatra Rutihinda | Leanié Moreau | Safia Chelighem | Ayman Oweida

Uncovering a connection between physiological stress and therapeutic resistance in tumor cells

JOURNAL ARTICLE published 2013 in Journal for ImmunoTherapy of Cancer

Authors: Jason W Eng | Chelsey Reed | Kathleen M Kokolus | Rose Pitoniak | Bonnie L Hylander | Elizabeth A Repasky

361 Heterogeneity of PD-1hi T cells associates with response to PD-1 blockade in hepatocellular carcinoma

JOURNAL ARTICLE published November 2021 in Journal for ImmunoTherapy of Cancer

Authors: Assaf Magen | Assaf Magen | Pauline Hamon | Myron Schwartz | Thomas Marron | Alice Kamphorst | Miriam Merad

S78. Proffered paper: High-affinity CD20-specific TCRs suitable for adoptive immunotherapy can be readily isolated from the allo-repertoire using reverse immunology

JOURNAL ARTICLE published March 2014 in Journal for ImmunoTherapy of Cancer

Authors: L Jahn | P Hombrink | C Hassan | MGD Kester | MP Schoonakker | JHF Falkenburg | P van Veelen | MHM Heemskerk

559 Preclinical evaluation of pegylated liposomal Doxorubicin or Doxorubicin with mATRC-101 in the EMT6 syngeneic mouse model

JOURNAL ARTICLE published November 2021 in Journal for ImmunoTherapy of Cancer

Authors: Danhui Zhang | Nikhil Vad | Erin Wechsler

135 Identification and characterization of an allogeneic iNKT-CAR targeting BCMA

JOURNAL ARTICLE published November 2021 in Journal for ImmunoTherapy of Cancer

Authors: Xavier Michelet | Eleni Chantzoura | Efrat Altman-Sharoni | Martyna Popis | Reed Masakyan | Paul Ibbett | Deborah Wright | Moira Pinzan Rossi | Marc Van Dijk

Exercise suppresses tumor growth through epinephrine- and IL-6-dependent mobilization and redistribution of NK cells

JOURNAL ARTICLE published 2015 in Journal for ImmunoTherapy of Cancer

Authors: Line Pedersen | Manja Idorn | Gitte Olofsson | Intawat Nookaew | Rasmus Hansen | Helle Johannesen | Jürgen C Becker | Britt Lauenborg | Katrine S Pedersen | Christine Dethlefsen | Jens B Nielsen | Julie Gehl | Bente Pedersen | Per thor Straten | Pernille Hojman

459 Phase 3 study of first-line pembrolizumab with and without vibostolimab (anti-TIGIT) in patients with PD-L1–positive metastatic NSCLC

JOURNAL ARTICLE published November 2021 in Journal for ImmunoTherapy of Cancer

Authors: Matthew Hellmann | Byoung Cho | Rosalyn Juergens | Ying Cheng | Gilberto de Castro | Mustafa Erman | Jessica Bauman | Toshiaki Takahashi | Paul Schwarzenberger | Pingye Zhang | M Catherine Pietanza | James Chih-Hsin Yang

Blockade of Treg derived TGF-β abrogates suppression of effector T cell function within the tumor microenvironment

JOURNAL ARTICLE published 2013 in Journal for ImmunoTherapy of Cancer

Authors: Sadna Budhu | David Schaer | Yongbiao Li | Alan Houghton | Samuel Silverstein | Taha Merghoub | Jedd Wolchok

120 Chemokine receptor engineering enhances trafficking and homing of primary and iPSC-derived CAR-T cells to solid tumors

JOURNAL ARTICLE published November 2021 in Journal for ImmunoTherapy of Cancer

Authors: Martin Hosking | Soheila Shirinbak | Joy Grant | Yijia Pan | Angela Gentile | Amit Mehta | Bjoern Gaertner | Bishwas Shrestha | Mochtar Pribadi | Jason ORourke | Alec Witty | Tom Lee | Bob Valamehr

Remembering the forgotten child: the role of immune checkpoint inhibition in patients with human immunod eficiency virus and cancer

JOURNAL ARTICLE published December 2019 in Journal for ImmunoTherapy of Cancer

Authors: Jacob J. Adashek | Pedro Nazareth Aguiar Junior | Natalie Galanina | Razelle Kurzrock

957 NKTR-255+cetuximab in patients with solid tumors: interim safety and efficacy results from the phase 1b dose-escalation study

JOURNAL ARTICLE published November 2021 in Journal for ImmunoTherapy of Cancer

Authors: Mehmet Altan | Amita Patnaik | Minal Barve | Lara Dunn | Patrick Cobb | Ari Rosenberg | Sunil Sharma | Ammar Sukari | Manish Patel | Xiaoli Wang | Haijun Ma | Neha Dixit | Wildaliz Nieves | Christie Fanton | Sue Currie | Zachary Lee | Mario Marcondes | Johnathan Zalevsky | Mary Tagliaferri | Assuntina Sacco

Chimeric tumor modeling reveals role of partial PDL1 expression in resistance to virally induced immunotherapy

JOURNAL ARTICLE published December 2019 in Journal for ImmunoTherapy of Cancer

Research funded by National Institute of Allergy and Infectious Diseases (1K22AI095372) | National Cancer Institute (1R01CA194090) | American Cancer Society (RSG-17-047-01-MPC) | Hollings Cancer Center, Medical University of South Carolina (P30 CA138313)

Authors: Mee Y. Bartee | Parker C. Dryja | Eric Bartee

NLRC5germline variants as potential pharmacogenomic markers for immune checkpoint inhibitors

JOURNAL ARTICLE published June 2023 in Journal for ImmunoTherapy of Cancer

Authors: Xiang-Yu Meng